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Abstract: The influence of comorbidities and worse physical status on mortality following total hip
replacement (THR) leads to the idea that patient-reported health status may also be a predictor of
mortality. The aim of this study was to investigate the relationship between patient-reported health
status before THR and the risk of dying up to 5 years post-operatively. For these analyses, we used
register data on 42,862 THR patients with primary hip osteoarthritis operated between 2008 and 2012.
The relative survival ratio was calculated by dividing the observed survival in the patient group by
age- and sex-adjusted expected survival of the general population. Pre-operative responses to the
five EQ-5D-3L (EuroQol Group) dimensions along with age, sex, education status, year of surgery,
and hospital type were used as independent variables. Results shown that, as a group, THR patients
had a better survival than the general population. Broken down by the five EQ-5D-3L dimensions we
observed differentiated survival patters. For all dimensions, those reporting extreme problems had
higher mortality than those reporting moderate or no problems. In conclusion, worse health status
according to the EQ-5-3L before THR is associated with higher mortality up to five years after surgery.
EQ-5D-3L responses may be useful in a multifactorial individualized risk assessment before THR.
Keywords: total hip replacement; PROMs; EQ-5D; mortality; register
1. Introduction
The success of total hip replacement (THR) for the treatment of symptomatic osteoarthritis (OA) of
the hip is well recognised and the operation has been described as the operation of the 20th century [1].
There is an anticipated increased demand in surgical intervention due to the ageing population and
the increase in obesity [2–4]. The short-term risk of dying following THR is low and has declined over
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the last decades [5–9]. The 90-day mortality for all patients, including those with surgery due to acute
hip fractures and tumours around the hip, has been reported to be 0.7% in Sweden [10]. In England
and Wales, the 90-day mortality for patients undergoing hip replacement because of OA was 0.3%
in 2011 [5]. Systematic reviews of 30- and 90-day mortality rates in patients undergoing hip or knee
replacements found an average 90-day mortality of 0.7% [9,11]. Except for the first post-operative
month, elective THR patients have a better relative survival than the general population [12–14].
This could be explained by selection bias involved in the decision to proceed with THR; medically fit
patients are more likely to be recommended for surgery then those with advanced comorbidities.
The relative mortality risk in the period after surgery is higher in males and younger
patients [9,12,14–16]. Other factors associated with increased risk of dying up to 90 days post-operatively
in THR patients are worse physical status, according to the American Society of Anaesthesiologists (ASA)
classification system, and comorbidities such as congestive heart failure, diabetes with complication, renal
failure, metastatic cancer, chronic obstructive pulmonary disease, dementia, liver disease, and peptic
ulcer disease [5,16].
The influence of comorbidities and physical status on mortality leads to the possibility that
patient-reported health status may also be a predictor of mortality after elective THR. The importance
of self-reported health status has previously been investigated and been shown to be a predictor of
mortality in the elderly population, as well as in the general population over the age of 16 years [17,18].
Although this has not been demonstrated in THR surgery, some studies in other fields like acute
coronary syndrome have demonstrated a relationship between worse patient-reported health status
and increased mortality [19,20].
The complexity of the interactions between different patient factors and their association with
different outcomes (such as pain level, functional status, reoperations, death, and other adverse
events) complicates accurate assessments of risks and expected benefits for individual patients. Ideally,
modifiable risk factors (such as poor diabetes control, preoperative anaemia, and smoking) should
be identified and adjusted in order to minimize risk of complications and improve health outcomes.
However, patients should not be excluded or deterred from surgery based on generalised information
that may inaccurately overestimate the risks. To facilitate the assessment of risks and benefits, a decision
aid providing individualised information on expected outcomes is warranted, which in return could be
beneficial in the consenting process. Hip replacement relieves pain and improves mobility, enhancing
quality of life for a non-life threatening problem, and patients elect to take the risk involved in surgery.
This situation contrasts with life-saving surgery for cancer or cardiac conditions. In the UK, mortality
rates for individual surgeons following elective hip replacement surgery have been published, and
this had led to much controversy [21,22].
The objective of this study is to investigate the relationship between patient-reported health status
as determined by the five EQ-5D-3L dimensions, the self-assessment of overall health using a visual
analogue scale (EQ VAS), and hip pain (according to a Visual Analogue Scale (VAS)) before THR and
the risk of dying up to five years post-operatively.
Given the low number of events, it is obvious that large datasets are required to investigate if
health status, as reported by the patient, is associated with risk of dying after THR. With routine
nationwide prospective collection of patient-reported outcome measures (PROMs), the Swedish Hip
Arthroplasty Register (SHAR) is well suited to investigate such relationships. The importance of
patient-focused registries to improve health, care, and science has been re-iterated in a recent work by
Nelson and colleagues and within the field of arthroplasty by Berry [23,24].
2. Materials and Methods
2.1. Data Sources, Patient Selection, and Measures
The SHAR runs a nationwide program collecting PROMs to routinely monitor patients undergoing
THR in Sweden [25,26]. PROMs data collection commenced in 2002, was gradually adopted, and
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reached full active nationwide coverage in 2008. Patients were asked to complete a PROMs survey at
their preoperative clinical visit. The response rate of this preoperative survey was 86% [25]. The data
available within the SHAR databases has been linked with Statistics Sweden using the Personal Identity
Number (PIN) as part of a larger research project and data have subsequently been anonymised.
The process of the linkage of the different databases has been described elsewhere [27]. The short
PROMs survey includes the EQ-5D-3L instrument (the descriptive system with five health dimensions:
mobility, self-care, usual activities, pain/discomfort, and anxiety/depression; and three severity
levels: no problems, moderate problems, and severe problems), the EQ VAS (self-assessment of
overall health ranging from 0 to 100) and a pain VAS (to assess hip pain ranging from 0 (no pain)
to 100 (worst imaginable pain)). These data are prospectively collected prior to surgery as part of
the pre-operative visit and recorded in the SHAR database. All patients reported to SHAR and
undergoing THR for the first time between 1 January 2008 and 31 December 2012 with a diagnosis
of osteoarthritis and complete pre-operative PROMs were included in this study. In order not to
violate the assumption of independent observations, it was first decided that a patient could only
contribute with data from one primary hip replacement. Subsequently, however, we decided to only
include the first hip to reduce heterogeneity. Additional to the PROMs, we obtained data on sex, age at
operation, hospital type (university, county, rural or private), date of operation, method of fixation,
and date of death, if applicable. The mortality data is obtained by cross-matching with the Swedish
Population Register, governed by the Swedish Tax Office [28]. Based on the unique personal identity
number, we obtained data on the educational level (highest completed level of education at time of
operation) through linkage to Statistics Sweden. We used low, middle, and high levels of education
to respectively describe the first 9 years of education (secondary school level), an extra 2 or 3 years
(college level), and higher education (university or similar). Using these selection criteria, we identified
42,862 patients for the study group (Figure 1). To a certain extent, the PROMs act as proxies for patient
comorbidities. We tested the association between the dimension of the EQ-5D-3L questionnaire and the
ASA class (American Society of Anaesthesiologists physical status classification) and the International
Classification of Diseases 10th revision (ICD-10) based Elixhauser comorbidity index [29].
2.2. Statistical Analyses and Software
Group comparison between survivors and deceased patients were conducted with Student’s t-test
for continuous variables and the χ2 test for categorical variables.
Survival data was summarised and illustrated with the help of relative survival curves. We opted
for relative survival over the classical Kaplan-Meier survival curves and Cox Proportional Hazards
in order to gain better insight, not only into the differences between the levels of the five EQ-5D-3L
dimensions, but also to be able to relate the survival of the patients to the general population.
The relative survival ratio r(t) is defined as the observed survival in the patient group divided by
the expected survival of a comparable group from the general population:
r(t) =
SO(t)
Sp(t)
(1)
where SO(t) denotes the observed survival in the studied group and SP(t) is the population or expected
survival [30]. The population or expected survival was estimated from publicly available mortality
tables tabulated for sex and age [31]. The population or expected survival was estimated from publicly
available mortality tables maintained by the Human Life-Table Database (http://www.lifetable.de/)
and Human Mortality Database (http://www.mortality.org).
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Multivariable modelling proceeded with time-transformed Cox Proportional Hazards [32]. EQ 
VAS and pain VAS were measured in units of 10. Model assumptions were checked with Brownian 
bridges [33]. We assumed that age might have a non-linear effect on survival. We fitted a model 
where age was modelled with cubic splines. However, information theoretic assessment with the 
Bayesian Information Criterion strongly favoured the linear model; thus, this approach was 
dropped. 
We used R v3.4 (R Core team, Vienna, Austria, 2016) for statistical calculations.  
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This study is part of a larger research project with the overall aim of performing a 
multidimensional outcomes assessment following hip replacement surgery, and developing an 
instrument to facilitate shared decision-making before hip replacement. All the investigations were 
carried out following the rules of the Declaration of Helsinki. Ethical review approval was obtained 
from the Regional Ethical Review Board in Gothenburg, Sweden (entry number 271-14) on 9 April 
2014. 
In accordance with the Swedish Patient Data Act (2008:355), patients receive information about 
being registered and have the full right to opt-out. All patients undergoing hip replacement surgery 
in Sweden are, unless they opt out, per definition enrolled in the scientific studies performed by 
and at the SHAR. 
Figure 1. Flowchart study design. THR: total hip replacement; OA: osteoarthritis; PROMs: patient-reported
outcome measures.
Multivariable modelling proceeded with time-transformed Cox Proportional Hazards [32].
EQ VAS and pain VAS were measured in units of 10. Model assumptions were checked with Brownian
bridges [33]. We assumed that age might have a non-linear effect on survival. We fitted a model where
age was modelled with cubic splines. However, information theoretic assessment with the Bayesian
Information Criterion strongly favoured the linear model; thus, this approach was dropped.
We used R v3.4 (R Core team, Vienna, Austria, 2016) for statistical calculations.
2.3. Research Ethics
This study is part of a larger research project with the overall aim of performing
a multidimensional outcomes assessment following hip replacement surgery, and developing an
instrument to facilitate shared decision-making before hip replacement. All the investigations were
carried out following the rules of the Declaration of Helsinki. Ethical review approval was obtained
from the Regional Ethical Review Board in Gothenburg, Sweden (entry number 271-14) on 9 April 2014.
In accordance with the Swedish Patient Data Act (2008:355), patients receive information about
being registered and have the full right to opt-out. All patients undergoing hip replacement surgery in
Sweden are, unless they opt out, per definition enrolled in the scientific studies performed by and at
the SHAR.
2.4. Availability of Data and Materials
The datasets generated and analysed for the current study are not publicly available but are
stored in Secure-online Data Access (SODA) servers within the Registercentrum Vastra Götaland,
Gothenburg, Sweden and can be made available upon reasonable request [27].
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3. Results
Of the 42,862 patients in the cohort, 1346 died in the follow-up period (range = 5.0 years,
mean = 2.4 years, Standard Deviation (SD) = 1.4 years). There were statistically significant differences
between survivors and deceased regarding sex, age at day of operation, hospital type, the five EQ-5D
dimensions, the EQ VAS, the pain VAS, and educational level (Table 1).
Table 1. Demographics and pre-operative, health-related quality of life of the 42,862 total hip
replacement patients. The data is summarized as absolute numbers and percentages for discrete
variables and means, and standard deviations (SDs) for continuous variables.
Alive Dead
p-Value
n = 41,516 n = 1346
Mobility (%)
No problems 3210 (7.7) 52 (3.9)
<0.001Moderate problems 38,190 (92.0) 1279 (95.0)
Severe problems 116 (0.3) 15 (1.1)
Self-care (%)
No problems 32,066 (77.2) 910 (67.6)
<0.001Moderate problems 9102 (21.9) 403 (29.9)
Severe problems 348 (0.8) 33 (2.5)
Usual activities (%)
No problems 16,086 (38.7) 460 (34.2)
<0.001Moderate problems 21,125 (50.9) 684 (50.8)
Severe problems 4305 (10.4) 202 (15.0)
Pain/discomfort (%)
No problems 631 (1.5) 16 (1.2)
<0.001Moderate problems 23,822 (57.4) 706 (52.5)
Severe problems 17,063 (41.1) 624 (46.4)
Anxiety/depression (%)
No problems 23,963 (57.7) 711 (52.8)
<0.001Moderate problems 16,079 (38.7) 568 (42.2)
Severe problems 1474 (3.6) 67 (5.0)
EQ VAS score (SD) 54.77 (22.17) 50.61 (21.76) <0.001
Pain VAS score (SD) 62.39 (15.91) 62.67 (17.34) 0.53
Females (%) 23,358 (56.3) 633 (47.0) <0.001
Age (SD) 67.70 (10.09) 75.76 (8.83) <0.001
Educational level (%)
low 14,018 (33.8) 658 (48.9)
<0.001middle 17,038 (41.0) 466 (34.6)
high 10,460 (25.2) 222 (16.5)
Hospital (%)
University 3018 (7.3) 117 (8.7)
<0.001
County 13,026 (31.4) 464 (34.5)
Rural 17,490 (42.1) 603 (44.8)
Private 7982 (19.2) 162 (12.0)
Fixation (%)
Cemented 28,237 (68.4) 1168 (87.0)
<0.001
Uncemented 6363 (15.4) 58 (4.3)
Hybrid 536 (1.3) 12 (0.9)
Reverse hybrid 5503 (13.3) 102 (7.6)
Resurfacing 639 (1.5) 2 (0.1)
As a group, THR patients had a better survival rate than the general population (Figure 2).
Females had a better survival rate than males. Of interest, the so-called protective effect of hip
replacement on mortality is more profound in the more advanced age group. Compared to patients
operated at university hospitals, patients operated at any other type of hospitals had a better survival rate.
Broken down by the five EQ-5D-3L dimensions, we observed differentiated survival
patterns (Figure 2).
Patients who reported no problems on any of the EQ-5D-3L dimensions had a better survival rate
than the general population and patients who reported moderate or severe problems. Patients who
reported moderate problems on any of the EQ-5D-3L dimensions had a better survival rate than the
general population and patients who reported severe problems. The worse the patient scored on any of
the EQ-5D-3L dimensions, the higher the hazard rates of increased mortality became. Only a relatively
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small number of patients (n = 131) reported severe problems on the mobility dimension, but they were
found to have worse survival than the general population; patients who reported severe problems on
the self-care dimension had a slight drop in survival probability straight after the operation. In the
time span of one to four years after the operation, these patients had a better survival rate than the
general population; after year four, the survival chances worsened. Patients who reported severe
problems on the dimensions of pain/discomfort, usual activities, and anxiety/depression had a better
survival rate than the general population. This pattern was reinforced by the multivariable regression
analysis (Table 2).
Reviewing the EQ VAS data, we also discovered an association with lower patient-reported overall
health in the non-survival group. The pain VAS was neither clinically nor statistically significantly
associated with a difference in survival.
Although we identified an association between a higher obtained educational level and improved
survival chances after THR, these differences were not statistically significant and should be interpreted
with caution.
Table 2. Results of the relative survival regression analysis on mortality after total hip replacement.
The results are presented as Hazard Rates (HR) and associated 95% confidence intervals (CI).
HR 95% CI
Mobility
No problems ref
Moderate problems 1.46 1.09–1.96
Severe problems 2.65 1.43–4.92
Self-care
No problems ref
Moderate problems 1.15 1.01–1.31
Severe problems 1.57 1.08–2.29
Usual activity
No problems ref
Moderate problems 1.05 0.93–1.20
Severe problems 1.28 1.06–1.56
Pain/discomfort
No problems ref
Moderate problems 1.07 0.64–1.77
Severe problems 1.20 0.71–2.00
Anxiety/depression
No problems ref
Moderate problems 1.09 0.96–1.22
Severe problems 1.24 0.95–1.62
EQ VAS (in units of 10) 0.95 0.92–0.98
Pain VAS (in units of 10) 0.96 0.92–1.01
Sex
Male ref
Female 0.86 0.76–0.96
Age 0.96 0.95–0.97
Operation Year 0.91 0.86–0.96
Education
Low ref
Middle 0.93 0.83–1.06
High 0.85 0.73–1.01
Hospital
University ref
County 0.79 0.65–0.97
Rural 0.82 0.67–1.00
Private 0.72 0.56–0.91
Fixation
Cemented ref
Uncemented 0.60 0.45–0.81
Hybrid 0.80 0.45–1.43
Reverse hybrid 0.94 0.76–1.16
Resurfacing 0.20 0.05–0.84
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We undertook a sensitivity analysis for the missing PROMs data (6506 patients) and we did 
not observe any significant difference in mortality between the two groups, and the baseline data 
was statistically significant (however, it lacked a clinically significant difference (Table 3 and  
Figure 3)). 
We observed a strong association between the dimensions of the EQ-5D-3L questionnaire and 
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Figure 2. Relative survival curves for the overall study population (A) and broken down by
the five dimensions of the EQ-5D-3L (B–F). All our survival analyses are based on recorded
PROMs preoperatively.
We undertook a sensitivity analysis for the missing PROMs data (6506 patients) and we did not
observe any significant difference in mortality between the two groups, and the baseline data was
statistically significant (however, it lacked a clinically significant difference (Table 3 and Figure 3)).
We observed a strong association between the dimensions of the EQ-5D-3L questionnaire and the
ASA score (p < 0.0001 for all five dimensions) and the Elixhauser index (p < 0.0001 for all 5 dimensions).
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Table 3. Demographics, socioeconomics, and surgery-related data of 43,096 total hip replacement
patients with PROMs data, and the 6506 total hip replacement patients without PROMs data. The data
is summarized as absolute numbers and percentages for discrete variables, and means and standard
deviations for continuous variables.
Missing PROMs Available PROMs
p-Value
n = 6506 n = 43,096
Females (%) 3676 (56.5) 24,139 (56.0) 0.466
Age (SD) 68.59 (11.16) 67.97 (10.16) <0.001
Educational level (%)
Low 2407 (37.0) 14,676 (34.1)
<0.001
Middle 2557 (39.3) 17,504 (40.6)
High 1453 (22.3) 10,682 (24.8)
Missing 89 (1.4) 234 (0.5)
Hospital (%)
University 687 (10.6) 3154 (7.3)
<0.001
County 2288 (35.2) 13,571 (31.5)
Rural 2239 (34.4) 18,194 (42.2)
Private 1292 (19.9) 8177 (19.0)
Fixation (%)
Cemented 4226 (65.0) 29,594 (68.7)
<0.001
Uncemented 1099 (16.9) 6451 (15.0)
Hybrid 107 (1.6) 551 (1.3)
Reverse hybrid 883 (13.6) 5627 (13.1)
Resurfacing 83 (1.3) 643 (1.5)
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[14,15]. The worse survival rate after THR in university hospitals compared to the other non-
university hospitals has been a constant in the annual reports of the SHAR 
(https://shpr.registercentrum.se/shar-in-english) and has been attributed to the difference in patient 
characteristics of the patients treated at university hospitals. 
Figure 3. Relative survival curves for the population with missing PROMs and available
PROMs. All our survival analyses are based on (present or absent) preoperative recorded PROMs.
Although there is a difference between the groups, the difference is not statistically significant (p = 0.07).
4. Discussion
Our findings suggest a lower mortality in patients operated with THR compared to the general
population. This finding is consistent with previous reports [12–14]. The reduced mortality risk is
probably due to the selection of healthier individuals that are fit enough to undergo a major elective
procedure and also have a preoperative medical assessment and optimization. This effect is more
profound in the more advanced age group. This is consistent with previous reports of both the
Norwegian and Swedish arthroplasty registers and might well be explained by selection bias [14,15].
The worse survival rate after THR in university hospitals compared to the other non-university
hospitals has been a const nt in th annual reports of the SHAR (https://shpr.registercentrum.se/shar-
in-english) and has been attributed to the difference in patient characteristics of the patients treated at
university hospitals.
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The analysis of the available data points indicates an increased mortality risk for patients who
pre-operatively report more problems in the EQ-5D-3L dimensions of mobility and self-care; however,
in our data there are only a limited number of patients reporting severe limitations. The level of
problems on the dimensions’ usual activities—pain/discomfort and anxiety/depression—and the EQ
VAS score had limited influence on the mortality risk. It is very likely that poorer pre-operative mobility
is associated with increased incidence of chronic comorbidities like diabetes and cardiopulmonary
disease. This assumption is corroborated by the strong association between the EQ-5D-3L dimensions
and the ASA classification and Elixhauser comorbidity index. There is evidence linking an increased
sedentary lifestyle with increased risk of hospitalization, cardiovascular disease, and mortality [34].
Jämsen et al. described a significant association between poorer mobility (inability to walk/walking
indoors only) and increased risk of early mortality in their single centre-analysis of 1998 hip and knee
replacements [16]. Nüesch et al. [35] described the influence of poor mobility on mortality in the
presence of osteoarthritis of the hip. They performed a population cohort study in the southwest of
England and reported the presence of walking disability as a major risk factor for increased mortality,
while pain and depression had a limited influence. In the field of heart failure no association was
found between self-reported decreased ability to self-care and increased mortality [36]. To the best
of our knowledge, no previous reports have been found on the influence of problems with self-care
on mortality in patients undergoing elective THR surgery. There has been some evidence on the
influence of problems with anxiety and/or depression on mortality in patients following THR, where
most studies report a lower mortality in patients with anxiety and depression [37,38]. In contrast, we
found a small negative influence of self-reported problems in the anxiety or depression dimension
on survival after elective THR, although this relationship did not reach statistical significance
in the multivariable regression analysis. The influence of the pre-operative hip pain VAS score
on post-operative mortality is negligible and likely not of any clinical nor statistical significance.
Asberg et al. were unable to identify a difference in all-cause mortality between individuals with and
without chronic musculoskeletal complaints in their prospective population-based cohort study, as
well as their systematic review [39,40].
The findings of our study are in agreement with the historical studies from Sweden and Manitoba,
based on a general population, and do suggest there is a relationship between worse self-reported
health and an increased risk of dying earlier following hip replacement surgery [17,18]. Bliemel et al.
studied the influence of pre-fracture quality of life and early mortality (within one year) and found
there was an association between surviving the first postoperative year and the EQ-5D score [41].
There is an increased awareness of the importance and validity of arthroplasty registers and
PROMs [42–45]. Arthroplasty registers traditionally report revision or mortality as the endpoint in
measuring success after joint replacement, but it is accepted that revision is only a single and relatively
crude marker of the success of the procedure. In a recent study comparing different hip arthroplasty
registers it was noted that only few registers have so far been collecting PROMs data, despite the fact
that these scores may be highly relevant in measuring the success of the intervention [43]. A change in
the type of data recorded in joint registries has been advocated [46,47].
The influence of pre-operative PROMs on postoperative PROMs has been described, but so far, no
association between pre-operative PROMs and mortality has been described [48,49]. With an increased
interest in outcomes measurement and early postoperative mortality, it is important to realise that
many factors, patient-related as well as procedure-related, might influence the outcome [9,16]. The risk
of dying is certainly an important consideration for the patient and should be discussed with the
individual patient as part of the consenting process.
The importance of using pre-operative recorded scores within orthopaedics was published by
Jansson et al. as he described the possibility of using the EQ-5D instrument in the pre-operative setting
within orthopaedic surgery, and specifically found that the postoperative scores following elective
THR were improving and reaching levels of an age- and sex-matched population [50]. They suggested
that the EQ-5D could be used as part of the discussions with the patients in the pre-operative setting.
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Using self-rated health and its association with risk of dying is likely to improve the understanding of
the risk to life to the patient. Discussions should be centered on the individual situation and risk to
an individual patient, and as such the increased mortality risk in patient with poorer pre-operative
mobility and increased problems with self-care might well be worth mentioning [51].
A recent decision by the UK Department of Health to publish mortality figures after elective
knee- and hip replacements for individual surgeons and hospitals highlights the need to consider
pre-operatively-gathered outcome scores in order to explain potential variations and poorer results [21].
We used the information of a nationwide surveillance program, using prospectively collected
data to analyse the association between the pre-operatively collected PROMs and the mortality up to
five years after THR surgery.
The SHAR has a recognized high coverage and completeness of data (>98%) and a high
response rate for the pre-operative PROMs collection (86%). We have also studied the relationship of
non-responders of the PROMs program in the postoperative period and are aware that non-responders
are usually having worse scores. A difference between preoperative non-responders and responders,
and the observed mortality, could not be established.
As with some of the observational and register studies there is an absence of a control group, and
as such we could not compare what would have happened to the patients with an increased risk of
dying if no surgery would have been performed. The EQ-5D-3L (none, moderate, extreme) has only
been recently (2016) upgraded to the EQ-5D-5L (none, minimal, moderate, many, extreme) within
the SHAR. We are aware that the five-level survey could well cause less ceiling effect and add more
nuance to this study [52].
5. Conclusions
It is increasingly recognised that registries are an essential tool to improve healthcare and
science. As with all observational studies, it is difficult to prove causation, but we were able to
provide associations between pre-operative, patient-reported factors and postoperative mortality.
Patients reporting severe problems in mobility, self-care, and usual activity prior to an elective THR
for primary osteoarthritis have a higher mortality up to five years after surgery. EQ-5D-3L responses
may be useful in a multifactorial, individualized risk assessment before THR. Whilst this study
does not need to be seen as a deterrent to performing surgery, it helps identify patients and patient
groups that are more at risk of an earlier terminal event, compared to an age- and sex-matched
population. Identifying preoperatively patients at increased risk, based on EQ-5D responses, improves
the engagement between the patient and the surgeon for the decision-making process and may further
improve the outcomes after THR.
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